Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
about
Neuromyelitis optica pathogenesis and aquaporin 4Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseasesNovel Insights and Therapeutics in Multiple SclerosisT cells in the central nervous system: messengers of destruction or purveyors of protection?Immunology of neuromyelitis optica: a T cell-B cell collaborationNeuroprotection in a novel mouse model of multiple sclerosisInebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesTertiary Lymphoid Organs in Central Nervous System AutoimmunityThe spectrum of MOG autoantibody-associated demyelinating diseasesRegulatory T cells in central nervous system injury: a double-edged swordMHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.Optic neuritis in neuromyelitis optica.Assessing optic nerve pathology with diffusion MRI: from mouse to human.Autoimmune T cell responses in the central nervous systemMyelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.B cells limit repair after ischemic acute kidney injury.Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.Experimental models of neuromyelitis optica.Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis opticaDifferential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.Experimental autoimmune encephalomyelitis in the mouse.Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a reviewPromoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells.Treatment of neuromyelitis optica: current debate.Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets.Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitisInfluenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report.Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells.Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.Immune tolerance in multiple sclerosis.Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.Experimental Autoimmune Encephalomyelitis in Mice
P2860
Q21245240-0E0F197C-159D-47C8-97DE-0C7F2B8C0EE3Q24273331-3EBA22E1-0A04-4CD6-BBE7-1F3B4A214220Q26784619-5D0433AB-B173-4AFC-82A7-542C8B088361Q27001059-3E697E57-6D60-4E9E-98E5-EBD2EECD6FF2Q27016045-35BBD177-AC82-4A28-B361-210DEA2E7333Q27302918-24E4978F-6C0D-4385-8AC9-CC622D5F604FQ28067334-5B056971-123B-4A1F-9960-9BD06057FD42Q28071379-986A36EE-EEC7-4C9F-AF99-7C953C21D69BQ28293355-2B3D194D-4B4F-45CE-9F23-56602A62011DQ30303089-0A6A7D14-07B2-4913-8290-9847C6E282D0Q30405378-BD4D1A88-33ED-46B1-A0AE-09A3BECB6EA6Q30483471-049522FA-2F6C-4624-BD5A-FD9446A0F96FQ30574747-D84527F5-8663-4FCB-9B68-6E59948A2066Q30610471-96F14624-6462-453B-8525-58EA89D8549CQ33364760-BB819B18-55BF-485D-9CA0-1B88FEDA688CQ33620003-50FBE068-B08E-4830-BB5D-DF42EEAF36A7Q33645795-3C9F3A0D-FE21-4BB9-A3A0-CFCAC2A3A144Q33725044-D528B0A7-88D6-4B11-A500-9A9FE47B16CFQ33748553-5E1EE029-C8FB-4CEE-B91E-8C458ADD3239Q33769028-6E8D11AC-C027-49D4-9C87-05F17946B10EQ33785380-8D5F8821-55D5-443F-805A-A1A692F2BDFFQ33802616-169B98DA-8597-41FD-BB2A-E960CA7FD28FQ33841113-4620D647-F79F-4604-8E26-03876B477E2DQ34041971-8E500B39-8E34-4013-8A28-C86024088012Q34096571-3B9FD6FC-CACC-46B4-9244-D552AA4D3FB8Q34158137-C8AA2414-E5F4-47CE-80B3-E459219785E8Q34182445-43B9158E-D47D-49E3-B442-52FA4D961172Q34409070-ABF30936-DA75-404C-84BA-0DFDF446E7E6Q34535993-EBD60543-CAA9-49BE-AB22-5BF60E4EEE00Q34540602-0DEDC54A-8A71-4FC4-AC80-63BEE9B8C18EQ34614563-1874F12A-55C7-4AA6-90A1-CEF083531ED5Q34636918-2C0BC3F1-9D7A-40C7-B70D-8598535EFCFCQ34645411-8A7B7502-3C6F-4715-BAB9-4DB542E2DBC8Q34796355-080BBB41-A143-4588-B859-5BED7054DC48Q34831296-D53C124A-214B-4F5E-B327-90990C0C65CBQ34942354-5F7582E6-C4CA-494F-BECD-E379DCCA4953Q35013113-9E179375-94BF-4CF2-A809-9D778A8012FCQ35106595-08AB52BC-A311-4C4D-82C6-89F845EB4C5AQ35179093-76C306B3-4315-4137-99F7-37901489E180Q35472583-C46FD349-8A63-40D8-895F-F4F9C16B8009
P2860
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Myelin oligodendrocyte glycopr ...... a Devic-like disease in mice.
@ast
Myelin oligodendrocyte glycopr ...... a Devic-like disease in mice.
@en
type
label
Myelin oligodendrocyte glycopr ...... a Devic-like disease in mice.
@ast
Myelin oligodendrocyte glycopr ...... a Devic-like disease in mice.
@en
prefLabel
Myelin oligodendrocyte glycopr ...... a Devic-like disease in mice.
@ast
Myelin oligodendrocyte glycopr ...... a Devic-like disease in mice.
@en
P2093
P2860
P356
P1476
Myelin oligodendrocyte glycopr ...... a Devic-like disease in mice.
@en
P2093
Anneli Jäger
Dominique Baeten
Estelle Bettelli
Raymond A Sobel
Vijay K Kuchroo
P2860
P304
P356
10.1172/JCI28334
P407
P577
2006-09-01T00:00:00Z